Active ingredientTeriparatideCat. No. P-T063-001CAS 52232-67-4Family · Pharmaceutical analytical standards
Teriparatide
A recombinant form of the first 34 amino acids of human parathyroid hormone, approved in the United States in 2002 and in Europe in 2003 for osteoporosis at high risk of fracture: it stimulates the formation of new bone. This family brings together the active ingredient and other impurities.
Did you know?The hormone's paradox: when it stays constantly high in the blood it wears bone away, while one small daily injection mainly activates osteoblasts and builds new bone tissue.
Go to the active ingredient →Active ingredientTeriparatideCat. No. P-T063-001CAS 52232-67-4
ImpurityTeriparatide succinimide (30) ImpurityCat. No. P-T063-023No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceTeriparatide CRSEDQM code Y0001916Family TeriparatideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.